Pharmaust Limited (AU:PAA) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PharmAust Limited reports a 9% decrease in revenues and a 24% increase in losses for the fiscal year ending June 30, 2024, compared to the previous year, with no dividends paid. The company’s net assets have shown a significant increase, rising to $10,228,243 from $3,889,135, while experiencing a loss of control over subsidiaries Epichem Pty Ltd and Epichem OHD Pty Ltd. The full annual report has been audited and is attached to the release.
For further insights into AU:PAA stock, check out TipRanks’ Stock Analysis page.